Screening for Down's syndrome based on individual risk

Area of Science:

• Prenatal diagnostics
• Biochemical screening
• Genetics

Background:

• Traditional Down's syndrome screening relies on maternal age and genetic history.
• Biochemical markers like chorionic gonadotrophin and alpha fetoprotein offer additional data.
• Accurate gestational dating is crucial for reliable screening results.

Purpose of the Study:

• To assess the effectiveness of individual biochemical screening for Down's syndrome risk.
• To compare biochemical screening with traditional methods based on maternal age and genetics.
• To evaluate resource utilization and detection rates for Down's syndrome.

Main Methods:

• Retrospective analysis of 3436 pregnancies screened for neural tube defects.
• Individual risk calculation using maternal age, serum chorionic gonadotrophin, and alpha fetoprotein levels.
• Comparison of screening outcomes with karyotype results and pregnancy outcomes.

Main Results:

• Biochemical screening detected 5 out of 8 Down's syndrome cases, with a 73% detection rate.
• This approach required screening 6.3% of pregnancies, a more efficient use of resources compared to age-based screening.
• Effectiveness was noted particularly for women over 35 years of age.

Conclusions:

• Individual biochemical screening for Down's syndrome is more resource-effective than maternal age and genetic history alone.
• This method maintains or improves detection rates, especially for older pregnant individuals.
• Optimized screening strategies can enhance prenatal care for Down's syndrome.